Lifecycle Leader - RAS Portfolio

Roche•San Francisco, CA

About The Position

The Lifecycle Leader for Roche’s broad RAS Portfolio, including a next-generation KRAS G12C inhibitor, leads the asset strategy and portfolio from research through to patients. The role leads the Life Cycle Team (LCT) and is accountable to the Late Stage Portfolio Committee (LSPC), maximizing product value for patients, society, and the company through an integrated, global, cross-functional strategy. The role shapes the portfolio’s long-term vision in partnership with early development, Pharma Development, Global Pharma Strategy, Medical Affairs leads, and external partners. It supports earlier lifecycle involvement and transition from early to late-stage development, as well as relevant early development asset teams, licensing, and business development activities. The Lifecycle Leader drives integrated decision-making with development, technical, and commercial teams; builds accountability and team capability; and serves as a thought partner to internal and external stakeholders. The role oversees resource requests and utilization, delivery of adjusted net present value (aNPV) commitments to LSPC, and ongoing assessment of asset strategy and value opportunities. It integrates proposals for indications, formulations, devices, diagnostics, digital tools, and evidence generation to address appropriate treatable populations.

Requirements

  • Bachelor’s degree; marketing, business management, or life sciences is preferred.
  • 12+ years of multidisciplinary biopharma experience.
  • Proven track record developing and executing breakthrough commercial or development strategies, product launches, and product management that deliver significant financial results.
  • Mandatory oncology and solid tumor experience.
  • 5+ years of global strategic leadership experience.
  • Demonstrated agility, long-term vision, and deep industry knowledge to craft innovative business strategies.
  • Proven ability to build and develop high-performing teams and lead in complex cross-functional environments.
  • Ability to navigate dynamic internal and external environments and deliver measurable value.

Nice To Haves

  • MD, PhD, relevant postgraduate degree, or MBA.
  • Expertise in RAS.
  • Strong understanding of technical, supply, development, regulatory, and global market access and reimbursement landscapes.

Responsibilities

  • Shape the long-term vision and strategy for the broad RAS Portfolio, including a next-generation KRAS G12C inhibitor, in partnership with relevant internal teams and external partners.
  • Support earlier lifecycle involvement and a seamless transition from early to late-stage development, including input into asset teams at critical points such as pivotal enabling Clinical Development Plans.
  • Support relevant early development asset teams, licensing, and other business development activities.
  • Drive alignment and integrated decision-making with the Global Development Team, Global Technical Team, and Commercial Leadership Team to realize asset potential within asset, disease-area, and therapeutic-area strategies.
  • Promote asset, disease-area, and enterprise thinking and develop team capabilities in line with OnePharmaStrategy.
  • Lead and inspire teams toward a shared vision while fostering accountability, collaboration, inclusion, and trust.
  • Act as a thought partner and sounding board for GPS and cross-organization teams and relevant internal and external stakeholders.
  • Be accountable for resource requests, appropriate resource utilization, and delivery of aNPV to the Late Stage Portfolio Committee.
  • Continuously assess and evolve asset strategy in response to external dynamics, opportunities, and disease-area strategy, evaluating and activating value levers.
  • Lead integrated proposals and delivery for indications, formulations, devices, diagnostics, digital tools, and evidence generation in collaboration with commercial, development, technical, and other teams.
  • Deliver product strategy on time, on target, and within budget, including key milestones and financial targets.
  • Develop and lead a high-performing team to create and deliver the asset strategy.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service